Cardiovascular
    Strong Evidence

    Homocysteine Reduction

    Lower cardiovascular risk marker levels.

    TL;DR

    B12, folate and B6 lower homocysteine reliably. The catch is that trials lowering it have not consistently reduced cardiovascular events, though stroke risk may fall modestly.

    Why It Matters

    Elevated homocysteine is associated with cardiovascular disease, cognitive decline and venous thrombosis, and markedly elevated levels can indicate B12 deficiency or an inherited metabolic disorder needing investigation.

    How to Measure

    Biomarkers

    Plasma homocysteine
    Serum B12 and methylmalonic acid
    Red cell folate
    Creatinine
    MTHFR status where relevant

    Optimization Protocol

    Check B12 and folate status first, since deficiency is the most common correctable cause. Supplement B12 at 500-1000 mcg daily if low, folate at 400-800 mcg, and B6 at 25-50 mg. Betaine at 3 g daily lowers homocysteine independently. Reduce alcohol and stop smoking, both of which raise levels.

    Supporting Supplements

    Supporting Research

    Frequently Asked Questions

    Can homocysteine be lowered?
    Reliably, yes. Folic acid at 0.4-1 mg/day with vitamin B12 and B6 lowers levels by roughly 25% in most people within 6-8 weeks.
    Does lowering it reduce heart attacks?
    Largely no. Major trials found lowering homocysteine did not reduce cardiac events, though some showed a modest reduction in stroke risk.
    Is B12 status important?
    Yes. Folic acid alone can lower homocysteine while masking B12 deficiency, so B12 should be checked or co-supplemented, particularly in older adults and vegans.
    What raises homocysteine?
    Low folate, B12 or B6, kidney impairment, hypothyroidism, smoking, heavy coffee intake, some medicines, and the MTHFR variants.
    Does MTHFR genotype change management?
    Rarely. Adequate folate intake normalises homocysteine in most carriers, and routine genotyping is not recommended for cardiovascular risk.
    When is testing worthwhile?
    In unexplained early vascular disease or recurrent clots, or where deficiency is suspected. It is not part of routine risk screening.

    Typical Timeframe

    6-12 weeks

    Research Summary

    Studies21
    Supplements3
    Evidence
    Strong Evidence

    My Notes

    Sign in to add personal notes

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.